دورية أكاديمية

The Role of Pelvic Exenteration in Cervical Cancer: A Review of the Literature.

التفاصيل البيبلوغرافية
العنوان: The Role of Pelvic Exenteration in Cervical Cancer: A Review of the Literature.
المؤلفون: Ubinha ACF; Department of Gynecologic Oncology, Barretos Cancer Hospital, São Paulo 14784-400, Brazil., Pedrão PG; Molecular Oncology Research Center, Barretos Cancer Hospital, São Paulo 14784-400, Brazil., Tadini AC; Barretos School of Health Sciences, Dr. Paulo Prata-FACISB, Barretos 14785-002, Brazil., Schmidt RL; Department of Gynecologic Oncology, Barretos Cancer Hospital, São Paulo 14784-400, Brazil., Santos MHD; Department of Gynecologic Oncology, Barretos Cancer Hospital, São Paulo 14784-400, Brazil., Andrade CEMDC; Department of Gynecologic Oncology, Barretos Cancer Hospital, São Paulo 14784-400, Brazil., Longatto Filho A; Molecular Oncology Research Center, Barretos Cancer Hospital, São Paulo 14784-400, Brazil.; Medical Laboratory of Medical Investigation (LIM), Department of Pathology, Medical School, University of São Paulo, São Paulo 01246-903, Brazil.; Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, 4710-057 Braga, Portugal.; ICVS/3B's-PT Government Associate Laboratory, 4710-057 Braga, Portugal.; ICVS/3B's-PT Government Associate Laboratory, 4805-017 Guimarães, Portugal., Reis RD; Department of Gynecologic Oncology, Barretos Cancer Hospital, São Paulo 14784-400, Brazil.
المصدر: Cancers [Cancers (Basel)] 2024 Feb 18; Vol. 16 (4). Date of Electronic Publication: 2024 Feb 18.
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Basel, Switzerland : MDPI
مستخلص: Pelvic exenteration represents a radical procedure aimed at achieving complete tumor resection with negative margins. Although it is the only therapeutic option for some cases of advanced tumors, it is associated with several perioperative complications. We believe that careful patient selection is related to better oncologic outcomes and lower complication rates. The objectives of this review are to identify the most current indications for this intervention, suggest criteria for case selection, evaluate recommendations for perioperative care, and review oncologic outcomes and potential associated complications. To this end, an analysis of English language articles in PubMed was performed, searching for topics such as the indication for pelvic exenteration for recurrent gynecologic neoplasms selection of oncologic cases, the impact of tumor size and extent on oncologic outcomes, preoperative and postoperative surgical management, surgical complications, and outcomes of overall survival and recurrence-free survival.
References: Eur J Surg Oncol. 2012 Oct;38(10):948-54. (PMID: 22818842)
Gynecol Oncol Rep. 2018 May 29;25:56-59. (PMID: 29998183)
World J Surg Oncol. 2020 Sep 2;18(1):234. (PMID: 32878646)
Gynecol Oncol. 2006 Dec;103(3):1023-30. (PMID: 16890276)
Gynecol Oncol. 2006 May;101(2):261-8. (PMID: 16426668)
Gynecol Oncol. 2011 Apr;121(1):131-4. (PMID: 21256580)
Gynecol Oncol. 2019 Jan;152(1):151-156. (PMID: 30414740)
Exp Ther Med. 2021 Oct;22(4):1060. (PMID: 34434274)
Arch Gynecol Obstet. 2019 Jul;300(1):161-168. (PMID: 31011878)
Gynecol Oncol. 2017 Nov;147(2):345-350. (PMID: 28822555)
Gynecol Oncol. 2021 Apr;161(1):39-45. (PMID: 33402282)
Am J Obstet Gynecol. 1972 May 15;113(2):239-46. (PMID: 5025878)
J Surg Oncol. 2007 Dec 1;96(7):560-8. (PMID: 17708548)
Int J Gynecol Cancer. 2011 Feb;21(2):397-402. (PMID: 21519200)
Gynecol Oncol Rep. 2021 Mar 31;36:100757. (PMID: 33898694)
Ann Surg Oncol. 2013 May;20(5):1694-700. (PMID: 23212765)
Cancer. 1995 Nov 15;76(10 Suppl):1948-55. (PMID: 8634986)
Gynecol Oncol. 2013 Jun;129(3):580-5. (PMID: 23480870)
J Minim Invasive Gynecol. 2011 Jan-Feb;18(1):59-63. (PMID: 20965794)
Radiother Oncol. 1988 Aug;12(4):289-96. (PMID: 3187069)
Dis Colon Rectum. 2014 Oct;57(10):1153-61. (PMID: 25203370)
Cancers (Basel). 2021 Dec 07;13(24):. (PMID: 34944783)
Gynecol Oncol. 2022 Jul;166(1):100-107. (PMID: 35568583)
Cancer. 1948 Jul;1(2):177-83. (PMID: 18875031)
Gynecol Oncol. 2023 Apr;171:114-120. (PMID: 36870097)
J Minim Invasive Gynecol. 2016 Mar-Apr;23(3):396-403. (PMID: 26723571)
Cancers (Basel). 2022 May 09;14(9):. (PMID: 35565474)
Surgery. 1992 May;111(5):518-26. (PMID: 1598671)
Cochrane Database Syst Rev. 2012 Feb 15;(2):CD003306. (PMID: 22336788)
Surg Oncol Clin N Am. 2005 Apr;14(2):289-300. (PMID: 15817240)
Obstet Gynecol. 1992 May;79(5 ( Pt 1)):773-7. (PMID: 1565364)
Gynecol Oncol. 1995 Jul;58(1):74-8. (PMID: 7789894)
Int J Gynecol Cancer. 2012 Jun;22(5):889-96. (PMID: 22617477)
Gynecol Oncol. 2021 Nov;163(2):294-298. (PMID: 34518053)
JAMA Surg. 2017 Mar 1;152(3):292-298. (PMID: 28097305)
J Chronic Dis. 1987;40(5):373-83. (PMID: 3558716)
Curr Oncol Rep. 2015 Mar;17(3):435. (PMID: 25687807)
J Surg Oncol. 2010 May 1;101(6):507-12. (PMID: 20401918)
Surg Endosc. 2018 Dec;32(12):4707-4715. (PMID: 30019221)
Clin Radiol. 2017 Apr;72(4):302-306. (PMID: 28108013)
Gynecol Oncol. 2006 Sep;102(3):513-6. (PMID: 16510172)
Obstet Gynecol. 1989 Jun;73(6):1027-34. (PMID: 2726106)
Br J Surg. 2015 Dec;102(13):1710-7. (PMID: 26694992)
J Urol. 2002 Feb;167(2 Pt 2):1140-5; discussion 1146. (PMID: 11905889)
J Minim Invasive Gynecol. 2019 Nov - Dec;26(7):1316-1326. (PMID: 30611973)
Gynecol Oncol. 2022 Jun;165(3):514-521. (PMID: 35487774)
Br J Radiol. 2021 Sep 1;94(1125):20201460. (PMID: 33960814)
Am J Obstet Gynecol. 1999 Feb;180(2 Pt 1):306-12. (PMID: 9988791)
Gynecol Oncol. 2009 Jul;114(1):64-8. (PMID: 19411097)
Int J Gynecol Cancer. 2013 May;23(4):755-62. (PMID: 23407096)
Gynecol Oncol. 2011 Jul;122(1):14-8. (PMID: 21444105)
Eur J Surg Oncol. 2023 Nov;49(11):107102. (PMID: 37801833)
J Obstet Gynaecol India. 2022 Feb;72(1):66-71. (PMID: 35125740)
Obstet Gynecol. 1987 Apr;69(4):617-21. (PMID: 3822305)
N Engl J Med. 1999 Apr 15;340(15):1137-43. (PMID: 10202164)
Gynecol Oncol. 2003 Dec;91(3):616-8. (PMID: 14675686)
Radiology. 2010 Jul;256(1):143-50. (PMID: 20574091)
Gynecol Oncol. 2022 May;165(2):393-400. (PMID: 35331571)
Obstet Gynecol. 1989 Dec;74(6):934-43. (PMID: 2586960)
Eur J Obstet Gynecol Reprod Biol. 2022 Jul;274:56-61. (PMID: 35584578)
Ann Surg. 2004 Aug;240(2):205-13. (PMID: 15273542)
Gynecol Oncol. 1987 Mar;26(3):374-80. (PMID: 2435621)
Int J Gynecol Cancer. 2005 May-Jun;15(3):475-82. (PMID: 15882172)
Int J Gynecol Cancer. 2014 Jun;24(5):916-22. (PMID: 24442006)
Gynecol Oncol. 2013 Jun;129(3):586-592. (PMID: 23369941)
Virchows Arch. 2023 Jun;482(6):935-966. (PMID: 37145263)
Eur J Surg Oncol. 2022 Jun;48(6):1362-1367. (PMID: 34998633)
Gynecol Oncol. 2012 May;125(2):404-8. (PMID: 22285844)
Int J Gynecol Cancer. 2008 Sep-Oct;18(5):1139-44. (PMID: 18053063)
Gynecol Oncol. 2011 Mar;120(3):374-9. (PMID: 21215437)
Int J Gynaecol Obstet. 2021 Oct;155 Suppl 1:28-44. (PMID: 34669203)
Ann Surg Oncol. 2019 Feb;26(2):523-530. (PMID: 30539489)
Gynecol Oncol. 2019 May;153(2):368-375. (PMID: 30792003)
Gynecol Oncol. 1990 Jun;37(3):363-6. (PMID: 2351320)
Gynecol Oncol. 1989 Oct;35(1):93-8. (PMID: 2792911)
Curr Oncol Rep. 2021 Apr 14;23(6):61. (PMID: 33852056)
Cancer. 1993 Oct 15;72(8):2389-93. (PMID: 8402454)
Gynecol Oncol. 2009 Nov;115(2):310-1. (PMID: 19628275)
Cancer. 1964 Oct;17:1267-70. (PMID: 14236759)
Gynecol Oncol. 2014 Sep;134(3):546-51. (PMID: 25014540)
Gynecol Oncol. 1999 Oct;75(1):99-102. (PMID: 10502433)
Gynecol Oncol. 2012 May;125(2):336-42. (PMID: 22261299)
Int J Gynecol Cancer. 2022 Jan;32(1):107-108. (PMID: 34711666)
Cancer Diagn Progn. 2022 May 3;2(3):308-315. (PMID: 35530642)
Eur Radiol. 2013 Oct;23(10):2906-15. (PMID: 23652852)
Surg Oncol. 2022 Mar;40:101702. (PMID: 35065392)
Eur J Surg Oncol. 2012 Apr;38(4):361-6. (PMID: 22265840)
Gynecol Oncol. 2005 Oct;99(1):153-9. (PMID: 16054678)
Eur J Surg Oncol. 2019 Oct;45(10):1787-1795. (PMID: 31255441)
Gynecol Oncol. 2012 Jun;125(3):604-9. (PMID: 22406639)
Int J Gynaecol Obstet. 2014 Jul;126(1):41-4. (PMID: 24786138)
فهرسة مساهمة: Keywords: cervical cancer; extended pelvic resection; pelvic exenteration; recurrent cervical cancer
تواريخ الأحداث: Date Created: 20240224 Latest Revision: 20240227
رمز التحديث: 20240227
مُعرف محوري في PubMed: PMC10886894
DOI: 10.3390/cancers16040817
PMID: 38398208
قاعدة البيانات: MEDLINE
الوصف
تدمد:2072-6694
DOI:10.3390/cancers16040817